Delivery Order SPE2DB22D1017-SPE2DB25FG0JP
Award Date
4/17/25
Potential Completion Date
4/18/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,073.54 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of April 13, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
This is a $5,036.81 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of January 24, 2025 and was awarded on January 23, 2025. AmerisourceBergen holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,204.87 firm fixed price contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of March 28, 2023 and was awarded on March 27, 2023. This delivery order is part of a larger $999,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,476.50 contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S medication. The contract has an ultimate completion date of May 17, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract is a Firm Fixed Price (FFP) delivery order with a ceiling value of $2,361.05 and a period of performance through April 14, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,793.11 firm fixed-price contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of July 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,176.00, is for the provision of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract is a firm-fixed-price, non-set-aside award with a completion date of February 12, 2024. AmerisourceBergen holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,036.83, is for the supply of Trelegy Ellipta 100-62.5-25 60S, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This is a $9,163.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of April 4, 2025 and does not have a set-aside designation, indicating open competition....
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,967.29, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a prescription medication. The contract has an ultimate completion date of March 27, 2025. This appears to be a component of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...